{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:08:11Z","timestamp":1769123291545,"version":"3.49.0"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Factor XIIIA (FXIIIA) levels are independent predictors of early prognosis after acute myocardial infarction (AMI) and the Valine-to-Leucine (V34L) single nucleotide polymorphism (SNP) seems associated with lower AMI risk. Since the long-term AMI prognosis merits deeper investigation, we performed an observational study evaluating relationships between FXIIIA residual levels, cardiovascular risk-factors, and inherited genetic predispositions. FXIIIA V34L was genotyped in 333 AMI patients and a five-year follow-up was performed. FXIIIA levels assessed at day-zero (d0) and four days after AMI (d4), and conventional risk factors were analyzed, focusing on the development of major adverse cardiovascular events (MACE). FXIIIA assessed at d0 and d4 was also an independent MACE predictor in the long-term follow-up (FXIIIAd0, Odds Ratio (OR) = 3.02, 1.79\u20135.1, p = 0.013; FXIIIAd4, OR = 4.46, 2.33\u20138.55, p = 0.0001). FXIIIAd4 showed the strongest MACE association, suggesting that the FXIIIA protective role is maximized when high levels are maintained for longer time. Conversely, FXIIIA levels stratified by V34L predicted MACE at a lesser extent among L34-carriers (Hazard Risk (HR)VV34 = 3.89, 2.19\u20136.87, p = 0.000003; HRL34-carriers = 2.78, 1.39\u20135.57, p = 0.0039), and V34L did not predict all MACE, only multiple-MACE occurrence (p = 0.0087). Finally, in survival analysis, heart failure and death differed significantly from stroke and recurrent ischemia (p = 0.0013), with FXIIIA levels appreciably lower in the former (p = 0.05). Overall, genetically-determined FXIIIA levels have a significant long-term prognostic role, suggesting that a pharmacogenetics approach might help to select those AMI patients at risk of poor prognosis in the need of dedicated treatments.<\/jats:p>","DOI":"10.3390\/ijms19092766","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T10:57:59Z","timestamp":1536922679000},"page":"2766","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5511-0133","authenticated-orcid":false,"given":"Lucia","family":"Ansani","sequence":"first","affiliation":[{"name":"Operative Unit of Cardiology, University Hospital S. Anna of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jlenia","family":"Marchesini","sequence":"additional","affiliation":[{"name":"Operative Unit of Cardiology, University Hospital S. Anna of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Pestelli","sequence":"additional","affiliation":[{"name":"Operative Unit of Cardiology, University Hospital S. Anna of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Andrea","family":"Luisi","sequence":"additional","affiliation":[{"name":"Operative Unit of Cardiology, University Hospital S. Anna of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Scillitani","sequence":"additional","affiliation":[{"name":"Operative Unit of Cardiology, University Hospital S. Anna of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Longo","sequence":"additional","affiliation":[{"name":"Centre of Haemostasis &amp; Thrombosis, Department of Biomedical and Specialty Surgical Sciences, Section of Medical Biochemistry, Molecular Biology &amp; Genetics, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Milani","sequence":"additional","affiliation":[{"name":"Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Serino","sequence":"additional","affiliation":[{"name":"Centre of Haemostasis &amp; Thrombosis, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8448-066X","authenticated-orcid":false,"given":"Veronica","family":"Tisato","sequence":"additional","affiliation":[{"name":"Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-6120","authenticated-orcid":false,"given":"Donato","family":"Gemmati","sequence":"additional","affiliation":[{"name":"Centre of Haemostasis &amp; Thrombosis, Department of Biomedical and Specialty Surgical Sciences, Section of Medical Biochemistry, Molecular Biology &amp; Genetics, University of Ferrara, 44121 Ferrara, Italy"},{"name":"University Center for Studies on Gender Medicine, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2174\/1381612822666151210122954","article-title":"Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics","volume":"22","author":"Gemmati","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1160\/TH14-11-0952","article-title":"Factor XIII-A dynamics in acute myocardial infarction: A novel prognostic biomarker?","volume":"114","author":"Gemmati","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2119\/2006-00049.Gemmati","article-title":"Factor XIIIA-V34L and factor XIIIB-H95R gene variants: Effects on survival in myocardial infarction patients","volume":"13","author":"Gemmati","year":"2007","journal-title":"Mol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11239-014-1059-4","article-title":"Factor XIII val34leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease","volume":"38","author":"Kreutz","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH11-04-0247","article-title":"Common variants in the haemostatic gene pathway contribute to risk of early-onset myocardial infarction in the italian population","volume":"106","author":"Guella","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.2009.07805.x","article-title":"Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women","volume":"146","author":"Siegerink","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.thromres.2007.05.012","article-title":"Decreased factor XIII levels in factor XIII a subunit Leu34 homozygous patients with coronary artery disease","volume":"121","author":"Bereczky","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Balogh, L., Katona, E., Mezei, Z.A., Kallai, J., Gindele, R., Edes, I., Muszbek, L., Papp, Z., and Bereczky, Z. (2018). Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients. Mol. Cell. Biochem., 1\u201311.","DOI":"10.1007\/s11010-018-3326-8"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1160\/TH14-01-0085","article-title":"Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation","volume":"112","author":"Hoppe","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12185-012-1064-3","article-title":"Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control","volume":"95","author":"Ichinose","year":"2012","journal-title":"Int. J. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000093562","article-title":"Role of coagulation factor XIII (F XIII) in angiogenesis and tissue repair","volume":"35","author":"Inbal","year":"2006","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.105.602094","article-title":"Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction","volume":"113","author":"Nahrendorf","year":"2006","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/eurheartj\/ehm558","article-title":"Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: Implications for FXIII therapy and antithrombin use in myocardial infarction","volume":"29","author":"Nahrendorf","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1160\/TH14-07-0625","article-title":"Coagulation factor XIII: A multifunctional transglutaminase with clinical potential in a range of conditions","volume":"113","author":"Dickneite","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCRESAHA.116.309955","article-title":"Novel risk markers and risk assessments for cardiovascular disease","volume":"120","author":"Thomas","year":"2017","journal-title":"Circ. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2141.1995.tb05376.x","article-title":"Molecular basis of inherited factor XIII deficiency: Identification of multiple mutations provides insights into protein function","volume":"91","author":"Anwar","year":"1995","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3727\/096368909788534988","article-title":"Intramyocardial injection of autologous platelet-rich plasma combined with transmyocardial revascularization","volume":"18","author":"Wehberg","year":"2009","journal-title":"Cell Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.carrev.2010.08.005","article-title":"Revaten platelet-rich plasma improves cardiac function after myocardial injury","volume":"12","author":"Mishra","year":"2011","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MCA.0b013e3282fc6165","article-title":"Effects of intramyocardial injection of platelet-rich plasma on the healing process after myocardial infarction","volume":"19","author":"Li","year":"2008","journal-title":"Coron. Artery Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1182\/blood.V93.3.897","article-title":"Genotype\/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity","volume":"93","author":"Anwar","year":"1999","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0037-1614074","article-title":"Ethnic heterogeneity of the factor XIII val34leu polymorphism","volume":"84","author":"Zago","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/blood.V92.8.2766","article-title":"The val34leu polymorphism in the a subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity","volume":"92","author":"Kangsadalampai","year":"1998","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V96.3.988","article-title":"The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure","volume":"96","author":"Ariens","year":"2000","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0037-1614073","article-title":"Effect of val34leu polymorphism on the activation of the coagulation factor XIII-A","volume":"84","author":"Wartiovaara","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2141.2002.03707.x","article-title":"Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men","volume":"118","author":"Kohler","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1538-7836.2003.t01-8-00115.x","article-title":"Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease","volume":"1","author":"Chatterjee","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1160\/TH03-07-0031","article-title":"Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, d-dimer, and clot firmness","volume":"90","author":"Kucher","year":"2003","journal-title":"Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/j.thromres.2010.05.027","article-title":"Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: A pilot study","volume":"126","author":"Schroeder","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3324\/haematol.10647","article-title":"Elevated factor XIII level and the risk of myocardial infarction in women","volume":"92","author":"Bereczky","year":"2007","journal-title":"Haematologica"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.ATV.0000231538.60223.92","article-title":"Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus","volume":"26","author":"Andrew","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1538-7836.2004.01080.x","article-title":"No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors","volume":"3","author":"Martini","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1160\/TH11-01-0027","article-title":"FXIII-A leu34 genetic variant in premature coronary artery disease: A genotype\u2013phenotype case control study","volume":"106","author":"Silvain","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614250","article-title":"Association of a common polymorphism in the factor XIII gene with myocardial infarction","volume":"79","author":"Kohler","year":"1998","journal-title":"Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/hq0202.102874","article-title":"Factor XIIIA val34leu polymorphism does not predict risk of coronary heart disease: The atherosclerosis risk in communities (ARIC) study","volume":"22","author":"Aleksic","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5603\/CJ.a2016.0070","article-title":"Association of factor XIII val34leu polymorphism and coronary artery disease: A meta-analysis","volume":"24","author":"Jung","year":"2017","journal-title":"Cardiol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacc.2004.09.051","article-title":"A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction","volume":"45","author":"Marin","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(03)00274-1","article-title":"Role of factor XIII val34leu polymorphism in patients <45 years of age with acute myocardial infarction","volume":"91","author":"Roldan","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_39","first-page":"5547","article-title":"Factor XIII-A val34leu polymorphism might beassociated with myocardial infarction risk: An updated meta-analysis","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1076029609355152","article-title":"Coagulation factor XIII-A val34leu polymorphism and the risk of coronary artery disease and myocardial infarction in a chinese han population","volume":"17","author":"Guodong","year":"2011","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajh.1104","article-title":"A common mutation in the gene for coagulation factor XIII-A (val34leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases","volume":"67","author":"Gemmati","year":"2001","journal-title":"Am. J. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1038\/s41598-018-26025-z","article-title":"Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients","volume":"8","author":"Szekely","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00246-014-0903-9","article-title":"Dynamics of factor XIII levels after open heart surgery for congenital heart defects: Do cyanotic and acyanotic patients differ?","volume":"35","author":"Bockeria","year":"2014","journal-title":"Pediatr. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with st-segment elevation of the european society of cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the european society of cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/eurheartj\/ehm610","article-title":"Factor XIII: The cement of the heart after myocardial infarction?","volume":"29","author":"Vanhoutte","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Nahrendorf, M., Weissleder, R., and Ertl, G. (2006). Does FXIII deficiency impair wound healing after myocardial infarction?. PLoS ONE, 1.","DOI":"10.1371\/journal.pone.0000048"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1067-1927.2004.012503.x","article-title":"Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension","volume":"12","author":"Gemmati","year":"2004","journal-title":"Wound Repair Regen."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/153857440403800506","article-title":"Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells","volume":"38","author":"Zamboni","year":"2004","journal-title":"Vasc. Endovasc. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jvs.2006.06.006","article-title":"Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers","volume":"44","author":"Tognazzo","year":"2006","journal-title":"J. Vasc. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jvs.2006.05.011","article-title":"Influence of gene polymorphisms in ulcer healing process after superficial venous surgery","volume":"44","author":"Gemmati","year":"2006","journal-title":"J. Vasc. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","article-title":"2014 ACC\/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)","volume":"66","author":"Hicks","year":"2015","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/9\/2766\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:20:32Z","timestamp":1760196032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/9\/2766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["ijms19092766"],"URL":"https:\/\/doi.org\/10.3390\/ijms19092766","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]}}}